Key Financial’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
Other funds holding XLO
Key Financial's XLO Position: Q3 2026 in Review
Key Financial held its Xilio Therapeutics (XLO) position steady in Q3 2026 at 59 shares worth $534. The position accounts for ﹤0.01% of the portfolio, ranked #1224.
Key Financial first reported a position in XLO in Q1 2023 and has held it in 15 quarters since. The position peaked at $2.63K in Q1 2023. 17 funds tracked by Wall St. Rank hold XLO as of Q3 2026.
- Key Financial held 59 shares of Xilio Therapeutics worth $534 as of Q3 2026.
- Key Financial left its Xilio Therapeutics share count unchanged in Q3 2026.
- Xilio Therapeutics made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1224 holding.
- Key Financial first reported a position in Xilio Therapeutics in Q1 2023 and has held it in 15 quarters since.
- Key Financial's Xilio Therapeutics position peaked at $2.63K in Q1 2023.
- 17 funds tracked by Wall St. Rank held Xilio Therapeutics as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.